GM-CSF–deficient mice are susceptible to pulmonary group B streptococcal infection
Open Access
- 15 February 1999
- journal article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 103 (4), 563-569
- https://doi.org/10.1172/jci5212
Abstract
Granulocyte-macrophage colony-stimulating factor (GM-CSF) gene-targeted mice (GM–/–) cleared group B streptococcus (GBS) from the lungs more slowly than wild-type mice. Expression of GM-CSF in the respiratory epithelium of GM–/– mice improved bacterial clearance to levels greater than that in wild-type GM+/+ mice. Acute aerosolization of GM-CSF to GM+/+ mice significantly enhanced clearance of GBS at 24 hours. GBS infection was associated with increased neutrophilic infiltration in lungs of GM–/– mice, while macrophage infiltrates predominated in wild-type mice, suggesting an abnormality in macrophage clearance of bacteria in the absence of GM-CSF. While phagocytosis of GBS was unaltered, production of superoxide radicals and hydrogen peroxide was markedly deficient in macrophages from GM–/– mice. Lipid peroxidation, assessed by measuring the isoprostane 8-iso-PGF2α, was decreased in the lungs of GM–/– mice. GM-CSF plays an important role in GBS clearance in vivo, mediated in part by its role in enhancing superoxide and hydrogen peroxide production and bacterial killing by alveolar macrophages.This publication has 49 references indexed in Scilit:
- Perspectives series: host/pathogen interactions. Mechanisms of nitric oxide-related antimicrobial activity.Journal of Clinical Investigation, 1997
- Granulocyte Macrophage Colony-Stimulating Factor Improves Survival in Two Models of Gut-Derived Sepsis by Improving Gut Barrier Function and Modulating Bacterial ClearanceAnnals of Surgery, 1994
- Involvement of Granulocyte-Macrophage Colony-Stimulating Factor in Pulmonary HomeostasisScience, 1994
- Cytokine enhancement of complement‐dependent phagocytosis by macrophages: synergy of tumor necrosis factor‐α and granulocyte‐macrophage colony‐stimulating factor for phagocytosis of Cryptococcus neoformansEuropean Journal of Immunology, 1992
- The Ability of Recombinant Murine Granulocyte-Macrophage Colony-Stimulating Factor to Protect Neonatal Rats from Septic Death Due to Staphylococcus aureusThe Journal of Infectious Diseases, 1990
- Granulocyte-Macrophage Colony-Stimulating Factor Augments Human Monocyte Fungicidal Activity for Candida albicansThe Journal of Infectious Diseases, 1990
- GM-CSF induces human neutrophil IgA-mediated phagocytosis by an IgA Fc receptor activation mechanismNature, 1988
- Recombinant granulocyte/macrophage colony-stimulating factor activates macrophages to inhibit Trypanosoma cruzi and release hydrogen peroxide. Comparison with interferon gamma.The Journal of Experimental Medicine, 1987
- Recombinant human granulocyte/macrophage colony-stimulating factor activates intracellular killing of Leishmania donovani by human monocyte-derived macrophages.The Journal of Experimental Medicine, 1987
- Human recombinant granulocyte-macrophage colony-stimulating factor increases cell-to-cell adhesion and surface expression of adhesion-promoting surface glycoproteins on mature granulocytes.Journal of Clinical Investigation, 1986